title: Mycophenolate mofetil immunosuppressive therapies increase the incidence of cytomegalovirus infection in renal transplantation.
authors.affiliation: Nephrology Department, Hospital 12 de Octubre, Madrid, Spain.
authors.forename: M A
authors.initials: MA
authors.lastname: Munoz
authors.forename: A
authors.initials: A
authors.lastname: Andrés
authors.forename: R
authors.initials: R
authors.lastname: Gallego
authors.forename: E
authors.initials: E
authors.lastname: Morales
authors.forename: J M
authors.initials: JM
authors.lastname: Morales
authors.forename: J M
authors.initials: JM
authors.lastname: Aguado
authors.forename: C
authors.initials: C
authors.lastname: Lumbreras
authors.forename: A
authors.initials: A
authors.lastname: Torres
authors.forename: J L
authors.initials: JL
authors.lastname: Rodicio
authors.forename: M
authors.initials: M
authors.lastname: Praga
mesh_terms: D000328:Adult; D000367:Age Factors; D000956:Antigens, Viral / Q000097:blood; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D003586:Cytomegalovirus Infections / Q000453:epidemiology* / Q000276:immunology / Q000503:physiopathology; D006084:Graft Rejection / Q000453:epidemiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D015994:Incidence; D016030:Kidney Transplantation / Q000276:immunology*; D008875:Middle Aged; D016853:Muromonab-CD3 / Q000627:therapeutic use; D009173:Mycophenolic Acid / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011183:Postoperative Complications / Q000453:epidemiology / Q000821:virology; D012189:Retrospective Studies; D014019:Tissue Donors / Q000706:statistics & numerical data
chemical_list: D000956:Antigens, Viral; D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D009173:Mycophenolic Acid